Monday, June 19, 2006

Biotechnology CEO Awarded MBE

The Chief Executive of a biotechnology company specialising in anti-cancer drug development has been recognised in the Queen's Birthday Honours List. Glyn Edwards, Chief Executive of Antisoma, has been recognised as a Member of the Order of the British Empire (MBE), for services to the biotechnology industry.

While at the helm, Glyn Edwards has steered Antisoma through a partnering with Roche. On the potential to risk to biotech through partnering with pharma and the subsequent loss of control, Edwards has suggested that the risk to biotech is mitigated by the investment in longer-term product development: "We think by having this wider, deeper, longer-term relationship covering multiple products we stand more chance of at least one of these products getting to market and being a great success."

The full list of honours is available from the BBC.

No comments: